Literature DB >> 5107780

Structure-activity relationships of anti-oestrogens with regard to interaction with 17-beta-oestradiol in the mouse uterus and vagina.

L Terenius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5107780     DOI: 10.1530/acta.0.0660431

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


× No keyword cloud information.
  18 in total

Review 1.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

2.  Oestrogenic, anti-oestrogenic and fertility effects of some triphenylethanes and triphenylethylenes related to ethamoxytriphetol (MER 25).

Authors:  E R Clark; V C Jordan
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

3.  Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.

Authors:  V Craig Jordan
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

4.  A new triphenylethylene compound, Fc-1157a. I. Hormonal effects.

Authors:  S Kallio; L Kangas; G Blanco; R Johansson; A Karjalainen; M Perilä; I Pippo; H Sundquist; M Södervall; R Toivola
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.

Authors:  J C Heuson; E Engelsman; J Blonk-Van Der Wijst; H Maass; A Drochmans; J Michel; H Nowakowski; A Gorins
Journal:  Br Med J       Date:  1975-06-28

6.  3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.

Authors:  G Kranzfelder; R W Hartmann; E von Angerer; H Schönenberger; A E Bogden
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

7.  Differential depletion of cytoplasmic high affinity oestrogen receptors after the in vivo administration of the antioestrogens, clomiphene, MER-25 and tamoxifen.

Authors:  R N Kurl; I D Morris
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

8.  Alpha-fetoprotein: the major high-affinity estrogen binder in rat uterine cytosols.

Authors:  J Uriel; D Bouillon; C Aussel; M Dupiers
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

Review 9.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

10.  High affinity binding of anti-oestrogen to the chick liver nuclear oestrogen receptor.

Authors:  C B Lazier; V C Jordan
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.